levofloxacin mesylate | Interleukin Related interleukin-related.com

Product Name :
levofloxacin mesylate

Search keywords :
Levofloxacin

drugId :
null

Target Vo:
Bacterial DNA gyrase

Target Vo Short Name :
Bacterial DNA gyrase

Moa_Name:
Bacterial DNA gyrase inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
1998

Origin Company_Name :

Active Company_Name :
China Resources Double-Crane Pharmaceutical Co Ltd

Active Indication_Name:
Bacterial Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Myosin heavy chain Antibody
Glutamate receptor 1 Antibody
PI3 Kinase p110 beta Antibody: PI3 Kinase p110 beta Antibody is an unconjugated, approximately 123 kDa, rabbit-derived, anti-PI3 Kinase p110 beta polyclonal antibody. PI3 Kinase p110 beta Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, cow, horse, rabbit background without labeling.

Author: Interleukin Related

Related Posts